BeyondSpring (BYSI) Assets (2015 - 2026)
BeyondSpring (BYSI) posted Assets of $18.4 million for Q1 2026, down 29.02% sequentially from $25.9 million in Q4 2025, and down 50.39% YoY from $37.1 million in Q1 2025.
BeyondSpring (BYSI) Assets (2015 - 2026) Analysis & Trends
BeyondSpring has reported Assets for 12 years, with the latest figure at $18.4 million in Q1 2026.
- Quarterly Assets fell 50.39% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.4 million (down 50.39% YoY) and the FY2025 annual result came in at $25.9 million, down 24.43% from the prior year.
- Assets fell to $18.4 million in Q1 2026 per BYSI's latest filing, from $25.9 million in the prior quarter.
- Over five years, Assets peaked at $63.8 million in Q2 2022 and troughed at $18.4 million in Q1 2026.
- A 5-year average of $33.2 million and a median of $31.0 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2025 and 2026: Assets jumped 48.55% in 2025, then slumped 50.39% in 2026.
- Over 5 years, Assets stood at $46.2 million in 2022, then slumped by 46.33% to $24.8 million in 2023, then soared by 38.32% to $34.3 million in 2024, then slipped by 24.43% to $25.9 million in 2025, then slipped by 29.02% to $18.4 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $18.4 million, $25.9 million, and $29.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - | 14.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.61 Mn |
| Mar 31, 2026 | 18.41 Mn |
| Dec 31, 2025 | 25.93 Mn |
| Sep 30, 2025 | 29.48 Mn |
| Jun 30, 2025 | 31.04 Mn |
| Mar 31, 2025 | 37.10 Mn |
| Dec 31, 2024 | 34.32 Mn |
| Jun 30, 2024 | 20.90 Mn |
| Dec 31, 2023 | 24.81 Mn |
| Jun 30, 2023 | 32.88 Mn |
| Dec 31, 2022 | 46.22 Mn |
| Jun 30, 2022 | 63.77 Mn |
| Dec 31, 2021 | 81.65 Mn |
| Sep 30, 2021 | 98.37 Mn |
| Jun 30, 2021 | 82.53 Mn |
| Mar 31, 2021 | 97.09 Mn |
| Dec 31, 2020 | 117.04 Mn |
| Sep 30, 2020 | 39.40 Mn |
| Jun 30, 2020 | 46.72 Mn |
| Mar 31, 2020 | 33.50 Mn |